ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
eLife21 小时
Molecular Feature-Based Classification of Retroperitoneal Liposarcoma: A Prospective Cohort ...
Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...